Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies

Thomas Van BlarcomOncology Research and Development, Pfizer Inc., South San Francisco, CA, USACorrespondence[email protected]

Kevin LindquistOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Zea MeltonOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Wai Ling CheungOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Chris WagstromOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Dan McDonoughOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Cendy Valle OsegueraOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Sheng DingOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Andrea RossiOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Shobha PotluriOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Purnima SundarOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Steven PittsOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Marina SirotaOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Meri Galindo CasasOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Yu YanOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Jeffrey JonesOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Zygy Roe-ZurzOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Surabhi Srivatsa SrinivasanOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Wenwu ZhaiOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Jaume PonsOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Arvind RajpalOncology Research and Development, Pfizer Inc., South San Francisco, CA, USA

Javier Chaparro-RiggersOncology Research and Development, Pfizer Inc., South San Francisco, CA, USACorrespondence[email protected]

Your download is now in progress and you may close this window